SCHEMBL475597

SCHEMBL475597

Nc1ccc([C]=O)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20917754 0.85 ALDH1A1 (0.64) —
SCHEMBL104811 0.83 APP (0.32) —
SCHEMBL2346917 0.75 ALDH1A1 (0.50) —
SCHEMBL9611200 0.73 APP (1.00) —
SCHEMBL4313279 0.73 MEN1 (0.57) —
SCHEMBL3149415 0.73 MMP3 (0.38) —
SCHEMBL864945 0.73 APP (1.00) —
SCHEMBL9099731 0.73 ALDH1A1 (0.48) —
SCHEMBL1070719 0.73 MAPT (0.35) —
SCHEMBL10789402 0.71 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118048375-A Light-sensitive degradable positive plasmid, construction method and application 郑州纳克智造生物科技有限公司 2024-05-17 — — CN claimed
WO-2024040076-A1 EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A CELL PENETRATNG PEPTIDE CLEAVABLE LINKER LONZA SALES AG (CH) 2024-02-22 — — WO claimed
WO-2024040073-A1 EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A CLEAVABLE LINKER LONZA SALES AG (CH) 2024-02-22 — — WO claimed
WO-2024040075-A1 EXTRACELLULAR VESICLE COMPRISING A BIOLOGICALLY ACTIVE MOLECULE AND A DUAL CLEAVABLE LINKER LONZA SALES AG (CH) 2024-02-22 — — WO claimed
EP-3442594-B1 BLOCK COPOLYMER FOR OVERCOMING DRUG RESISTANCE OF TUMOURS TO CHEMOTHERAPY, ITS POLYMER-DRUG CONJUGATE, PHARMACEUTICAL COMPOSITION CONTAINING THEM, METHOD OF PREPARATION AND USE THEREOF USTAV MAKROMOLEKULARNI CHEMIE AV CR V V I (CZ) 2024-02-07 — — EP claimed
CN-117510500-A Preparation method of asperazepanones alkaloid and application of asperazepanones alkaloid as anti-inflammatory drug 中国海洋大学 2024-02-06 — — CN claimed
CN-117050043-A 3-phenyl dibenzofuran compound and preparation method and application thereof 中国海洋大学 2023-11-14 — — CN claimed
CN-116726010-A Application of macrolide derivative in preparation of medicines for inhibiting pro-inflammatory cytokine acting agents 中国海洋大学 2023-09-12 — — CN claimed
EP-2552202-B1 METHODS AND COMPOSITIONS FOR WEIGHT LOSS SDG INC (US) 2023-07-26 — — EP claimed
CN-116072878-B Electrode, preparation method thereof and lithium ion battery 东莞澳中新材料科技股份有限公司 2023-06-30 — — CN claimed
WO-1985000521-A1 ENZYME DERIVATIVES BEECHAM GROUP P.L.C. (GB) 1985-02-14 — — WO claimed
EP-0092830-A2 Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application CIBA-GEIGY AG (CH) 1983-11-02 — — EP claimed
EP-0091240-A2 Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them BEECHAM GROUP PLC (GB) 1983-10-12 — — EP claimed
US-4343885-A PHOTORESISTS DYNACHEM CORPORATION (US) 1982-08-10 — — US claimed
EP-0049601-A2 Sunscreen compositions containing delta-5,7 steroidal dienes THE MASSACHUSETTS GENERAL HOSPITAL (US) 1982-04-14 — — EP claimed
US-4314988-A Folic acid derivatives and process for preparation BAKER INSTRUMENTS CORP. (US) 1982-02-09 — — US claimed
US-4310511-A Sunscreen compositions containing Δ5,7 steroidal dienes MASSACHUSETTS GENERAL HOSPITAL (US) 1982-01-12 — — US claimed
US-4273773-A IN COMBINATION WITH A DIURETIC AMERICAN HOME PRODUCTS CORPORATION (US) 1981-06-16 — — US claimed
US-4045549-A Sulfonium salt substantive sunscreen compositions COLGATE-PALMOLIVE COMPANY (US) 1977-08-30 — — US claimed
US-4016146-A Phenethylamine antigenic conjugates, their preparation, antibodies, and use BIOLOGICAL DEVELOPMENTS, INC. (US) 1977-04-05 — — US claimed
Send feedback